Modern Vaccines Adjuvants Formulation

18-20 May 2016, Eigtveds Pakhus, Copenhagen, Denmark

  • Increase font size
  • Default font size
  • Decrease font size

Day Two

Final Conference Programme | Thursday 19th May 2016

Vaccines and vaccination

Session Moderator: Jean Haensler (Sanofi Pasteur, Lyon, France)

‘Optimization of aluminum salts formulations for inactivated poliovirus vaccine dose-sparing’
Livia Brunner (University of Lausanne, Epalinges, Switzerland)

‘New adjuvants for FMD vaccines’

Satya Parida (The Pirbright Institute, Guildford, UK)

‘A novel vaccination protocol for the induction of local IgA responses against genital C. trachomatis infections – the key role of vaccine-induced Th17 cells’
Frank Follmann (Statens Serum Institut, Copenhagen, Denmark)

Wrap-up by Session Moderator

Coffee Break & Posters

Short Poster Presentations

Session Moderator: Dennis Christensen (Statens Serum Institut, Copenhagen, Denmark)

11:25-11:40 – POSTERS 108 & 109
‘Novel carbohydrate monosulphate ester (CMS) adjuvants with high E/T-ratio and their potentials for single-shot vaccines’
Luuk Hilgers, Peter Paul Platenburg, Anneke Blom, Jeffrey Bajramovic and Han van den Bosch (LiteVax BV, Oss, The Netherlands)

11:40-11:55 – POSTER 103
‘Recombinant lipoimmunogen-based cancer immunotherapy’
Shih-Jen Liu and Chih-Hsiang Leng (National Institute of Infectious Diseases and Vaccinology and National Health Research Institutes, Miaoli, Taiwan)

11:55-12:10 – POSTER 104
‘Recombinant lipoprotein induces broad spectrum of cellular and humoral immune responses without exogenous adjuvant formulation’
Chen-Yi Chiang 1, Shih-Jen Liu 1,2, Chun-Hsiang Hsieh 1, Mei-Yu Chen 1, Jy-Ping Tsai 1, Hsueh-Hung Liu 1, I-Hua Chen 1, Pele Chong 1,2, Chih-Hsiang Leng 1,2 and Hsin-Wei Chen 1,2 (1 National Institute of Infectious Diseases and Vaccinology, Miaoli, Taiwan: 2 National Health Research Institute, Miaoli, Taiwan)

12:10-12:25 – POSTER 113
‘Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria: modulation of CD8 T cell responses and correlates of protection’
Anita Milicic 1, Christine Rollier 2, Choon Kit Tang 1, Karolis Bauza 1, Rhea Longley 3, Adrian V.S. Hill 1 and Arturo Reyes-Sandoval 4 (1 The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK; 2 Oxford Vaccine Group, University of Oxford and the NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK; 3 Population Health and Immunity, Walter & Eliza Hall Institute, Parkville, Australia and Mahidol Vivax Research Unit (MVRU), Mahidol University, Bangkok, Thailand; 4 The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK)

12:25-12:35 – POSTER 111
‘Overcoming the cold-chain distribution hurdle: Development of a lyophilized thermostable single vial adjuvanted vaccine against tuberculosis’
Michelle Y. Chan, Alicia M. Schwartz, Dawn M. Fedor, Quinton M. Dowling, Elyse A. Beebe, Liam Kapilow-Cohen, Thomas S. Vedvick, Mark T. Orr, Christopher B. Fox and Ryan M. Kramer
(Infectious Disease Research Institute (IDRI), Seattle, Washington, USA)

Wrap-up by Session Moderator

Lunch Break & Posters


Session Moderator: Manmohan Singh (Takeda Vaccines Inc., Morrisville, North Carolina, USA)

‘Challenges in development of formulations with adjuvants’
Lakshmi Khandke (Pfizer Vaccine Research, Pearl River, New York, USA)

‘Formulation of vaccines/adjuvants with Microfluidizers and upscalable methods’
Yvonne Perrie (Aston University, Aston, Birmingham, UK)

‘Formulation of influenza T cell peptides’
Gideon Kersten (Intravacc, Bilthoven, The Netherlands)

‘Activation of innate and adaptive immune responses by formulation with a polymer-based combination adjuvant’
S. van Drunen Littel-van den Hurk 1,2, R. Garg 1, I. Sarkar 1,2, V. Gerdts 1,3 and A. Potter 1,3 (1 VIDO-Intervac: 2 Microbiology & Immunology, Veterinary Microbiology: 3 University of Saskatchewan, Saskatoon, Canada)

Tea Break & Posters

‘Immunostimulating saponin-based nanoparticles: NanoQuil™ adjuvant’

Kefei Hu (Brenntag Biosector, Frederikssund, Denmark)

‘Insights to the mechanism of action of the mucosal adjuvant Endocine’
Anna-Karin Maltais (Eurocine Vaccines AB, Solna, Sweden)

Wrap-up by Session Moderator


MVAF 2016 Delegates

Login details will be supplied after you have registered for the event.

MVAF 2016 Sponsors

  • Brenntag
  • Vaxart
  • Sanofi Pasteur
  • Seppic
  • NanoTemper Technologies
  • IntraVacc
  • IDRI
  • EVI
  • hVIVO
  • Inovio
  • Mucosis
  • Aldevron
  • Bioaster
  • Pfizer
  • CureVac

MVAF 2016 Downloads

MVAF 2016 Leaflet

MVAF 2016 Mailing List

E-mail Address
What is 3+2-1?